Testing the DENVER protocol for autism
Part of Mental health clinical trials.
This study tests a tool to measure how well the DENVER protocol works for children with autism. It may help families decide if the protocol is a good fit for their child.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You and your child must speak French fluently.
- Your child must have a diagnosis of autism (ASD) made by a doctor using the DSM-5.
- Your child must not have a known brain condition (like epilepsy) or a genetic syndrome.
- Both parents or legal guardians must agree in writing for your child to take part.
- Your child cannot have major hearing or vision problems that aren't corrected by glasses or hearing aids.
- If your child is in the typically developing group, they cannot have a known developmental, brain, or psychiatric condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a parent-led program (with PACT) can improve autism-related symptoms in children. It focuses on giving parents structured support, and it compares outcomes after families complete the program.
This trial records a child’s brain activity using a painless EEG (small sensors on the scalp) to see how well it can predict later language development. It may help researchers understand which children are likely to improve and when.
This study compares an early autism opinion made by a community general pediatrician with a more detailed team assessment. It may help improve how families get autism evaluations sooner and more accurately.
This study tests a new French questionnaire (AMSE) to see how well it can identify autism in adults who are seeking a first diagnosis. It may help you get a clearer answer about whether you have autism.
This study looks at how a brain chemical related to calming signals (“GABA”) may affect how people process sounds in autism. The goal is to understand brain function during hearing tasks, which could help guide future treatments.
This trial tests a device called the NeuroCytotron to see if it can help people with autism. It is for individuals aged 3 to 50 who have a confirmed autism diagnosis and are medically stable.
Hear when a new Autism spectrum disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.